Back to mobile site

More on AUTL

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.0 Score)
- Holders

Upcoming Events

- Earnings (10/29/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Autolus Therapeutics (NQ:AUTL)
Delayed: 1.92 +0.05 (2.67%)
Prev. Close $1.87  
Open$1.92 
52 Wk High$ 
52 Wk Low$ 
Day High$1.95 
Day Low$1.89 
P/E N/A  
EPS$ 
Volume1,090,995 

Friends, Peers and Foes (?): A, AVBP, IPH, IPHA, 0A3M (more...)

Sep 15, 2026 04:22 PM Form DEL AM Autolus Therapeutics
Sep 14, 2026 06:02 AM Form S-3 Autolus Therapeutics
Sep 9, 2026 07:01 AM FDA grants RMAT designation to Autolus drug for lupus treatment
Sep 9, 2026 07:00 AM Autolus Therapeutics Announces FDA RMAT Designation Granted to Obe-cel for the Treatment of Systemic Lupus Erythematosus and Lupus Nephritis
Aug 28, 2026 09:08 PM Form SCHEDULE 13D/A Autolus Therapeutics Filed by: PPF Group a.s.
Aug 14, 2026 10:02 AM Form SCHEDULE 13G/A Autolus Therapeutics Filed by: ARMISTICE CAPITAL, LLC
Aug 11, 2026 04:15 PM Form 10-Q Autolus Therapeutics For: Jun 30
Aug 11, 2026 07:34 AM Form 8-K Autolus Therapeutics For: Aug 11
Aug 11, 2026 07:16 AM Autolus Therapeutics (AUTL) Tops Q2 EPS by 8c
Aug 11, 2026 07:00 AM Autolus Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates
View All Articles

Entities mentioned with AUTL

View All Entities